MAP3K11 and pulmonary fibrosis: In addition, the changes in the expression levels of miRNA and lncRNA can be used as biomarkers for disease strategy and/or assessment of drug action.45 In general, our study on the regulation of the activated epithelial cell proliferation in pulmonary fibrosis by lnc-PCF and miR-344a-5p-targeted map3k11 introduces a new approach to examine the complex post-transcriptional regulatory networks and present new therapeutic approaches to pulmonary fibrosis.